title: Therapy: oral or subcutaneous methotrexate for rheumatoid arthritis?
authors.affiliation: King Fahd Hospital, Jeddah 21921, PO Box 176, Saudi Arabia.
authors.forename: Sabri
authors.initials: S
authors.lastname: Alsaeedi
authors.affiliation: Mount Sinai Hospital, 60 Murray Street, Room 2-006, Toronto, ON M5T 3L9, Canada.
authors.forename: Edward C
authors.initials: EC
authors.lastname: Keystone
mesh_terms: D000284:Administration, Oral; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D008727:Methotrexate / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate
references.citation: Arthritis Care Res (Hoboken). 2012 May;64(5):625-39
references.pmid: 22473917
references.citation: Ann Rheum Dis. 2009 Jul;68(7):1086-93
references.pmid: 19033291
references.citation: Arthritis Care Res (Hoboken). 2014 Nov;66(11):1604-11
references.pmid: 24942466
references.citation: Arthritis Rheum. 2008 Jan;58(1):73-81
references.pmid: 18163521
references.citation: J Rheumatol. 2004 Apr;31(4):645-8
references.pmid: 15088287
references.citation: Ann Rheum Dis. 2014 Mar;73(3):492-509
references.pmid: 24161836
references.citation: Ann Rheum Dis. 2010 Oct;69(10):1849-52
references.pmid: 20511610
references.citation: Clin Rheumatol. 2013 Nov;32(11):1605-12
references.pmid: 23835658
references.citation: Ann Rheum Dis. 2014 Aug;73(8):1549-51
references.pmid: 24728329